Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
JAK Inhibitor Improves Symptoms in Patients With Psoriatic Arthritis and Axial Involvement
04/21/2023
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing upadacitinib to placebo and adalimumab, upadacitinib improved symptoms in patients with psoriatic arthritis and axial involvement.
In two phase 3 studies comparing...
04/21/2023
First Report Managed Care
News
Obesity Drug Comparison Ranks Semaglutide Tops for Weight Loss, Waist Reduction
06/27/2023
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and...
06/27/2023
First Report Managed Care
News
Bezlotoxumab Effective for Preventing Recurrent Clostridioides difficile Infection
08/09/2023
A meta-analysis has found that bezlotoxumab, a monoclonal antibody, may be effective in reducing the risk of recurrent CDI and could be a cost-effective addition to standard of care therapy.
A meta-analysis has found that bezlotoxumab, a monoclonal antibody, may be effective in reducing the risk of recurrent CDI and could be a cost-effective addition to standard of care therapy.
A meta-analysis has found that...
08/09/2023
First Report Managed Care
News
Intraocular Injection Recalled
06/06/2024
Imprimis NJOF is recalling 14,180 vials of epinephrine-lidocaine for intraocular injection due to a lack of assurance of sterility.
Imprimis NJOF is recalling 14,180 vials of epinephrine-lidocaine for intraocular injection due to a lack of assurance of sterility.
Imprimis NJOF is recalling...
06/06/2024
Pharmacy Learning Network
News
HIV Medication Recalled
06/13/2024
GlaxoSmithKline LLC is recalling 463 cartons of Tivicay PD because the product box lists incorrect expiration information.
GlaxoSmithKline LLC is recalling 463 cartons of Tivicay PD because the product box lists incorrect expiration information.
GlaxoSmithKline LLC is recalling...
06/13/2024
Pharmacy Learning Network
News
Medium-Dose Lithium May Hit Parkinson Disease Targets, but Tolerability Questioned
06/07/2023
Despite promising findings, this pilot study suggests that medium-dose lithium may be associated with tolerability issues when used to treat patients with Parkinson disease. 
Despite promising findings, this pilot study suggests that medium-dose lithium may be associated with tolerability issues when used to treat patients with Parkinson disease. 
Despite promising findings, this...
06/07/2023
Annals of Long-Term Care
News
Study Finds No Evidence Prenatal Benzodiazepine Exposure Heightens ADHD, ASD Risk
01/12/2023
Exposure to benzodiazepines in utero is not associated with increased risks of autism spectrum disorder (ASD) or ADHD, study finds.
Exposure to benzodiazepines in utero is not associated with increased risks of autism spectrum disorder (ASD) or ADHD, study finds.
Exposure to benzodiazepines in...
01/12/2023
Psych Congress Network
LTC Bulletin Board
Study Identified Three Important Aspects of Quality of Life for Residents with Dementia
06/01/2015
A new study found three themes important to the quality of life of long-term care residents with dementia
A new study found three themes important to the quality of life of long-term care residents with dementia
A new study found three themes...
06/01/2015
Annals of Long-Term Care
News
Statin Recall Grows
06/24/2021
A recall is active for a prescription statin used to treat high cholesterol and triglyceride levels.
A recall is active for a prescription statin used to treat high cholesterol and triglyceride levels.
A recall is active for a...
06/24/2021
Pharmacy Learning Network
News
OTC Pain Reliever Recalled Over Labeling Error
07/29/2021
The FDA has issued a recall for an over-the-counter medication used to treat mild to moderate pain and reduce fever.
The FDA has issued a recall for an over-the-counter medication used to treat mild to moderate pain and reduce fever.
The FDA has issued a recall for...
07/29/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
December 9 ⁠–⁠ December 11
AIBD logo
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use